Content
All Posts > Content under Pharma/Biotech
Week In Review: How Trump's Policies Moved Stocks - Sunday, May 10
8 Monster Stock Market Predictions For The Week Of May 11
Article By:
Michael J. Kramer
Read
Sunday, May 10, 2020 10:26 AM EDT
Economic news will be less prominent this week, but we will see a big options expiration on Friday. The most significant open interest level on the board is at 3,000, and that may pull the S&P 500 higher this week towards that strike price.
Are Biotech ETFs In Trouble As Coronavirus Dims Guidance?
Article By:
Zacks Investment Research
Read
Saturday, May 9, 2020 7:49 PM EDT
Although the coronavirus seems to be opening up opportunities for biotech companies, it is dampening their guidance as well. Despite impressive results, most of these biotechs have been seeing declining share prices since the earnings releases.
Week In Review: Junshi Out-Licenses Ex-China Rights For COVID-19 Therapeutic To Lilly
Article By:
ChinaBio® Today
Read
Saturday, May 9, 2020 2:40 PM EDT
Junshi Biosciences out-licensed ex-China rights for a therapeutic antibody aimed at preventing and treating COVID-19 to Eli Lilly. Lilly plans to file an IND and start trials in the US in Q2 of 2020.
Cronos Group's Q1 Financials Show Some Improvement But Still Operating At A Loss
Article By:
Lorimer Wilson
Read
Friday, May 8, 2020 1:17 PM EDT
Cronos Group Inc. has reported its financial results for Q1 of 2020 and they were less than impressive showing only slight improvement as outlined below:
In this article: CRON
Non-Penny Pot Stock Index Down 0.4% Thursday: Here Are The Biggest Winners & Losers
Article By:
Lorimer Wilson
Read
Friday, May 8, 2020 3:22 AM EDT
The Non-Penny Pot Stock Index (NPSI) of 35 stocks went down 0.4% on Thursday. 22 constituents advanced, 10 declined and 3 had no change in price. In addition, 4 categories went up and 5 categories went down in price.
Futures Soar On Chinese Exports, Trade Talk Optimism, Oil Spike
Article By:
Tyler Durden
Read
Thursday, May 7, 2020 9:37 AM EDT
US equity futures rebounded from Wednesday's slump, climbing alongside stocks in Europe on Thursday following an unexpected jump in Chinese exports and, drumroll, and optimism of trade talks between the US and China.
The Fastest Growing Industries During The Corona Lockdown
Article By:
Tea Muratovic
Read
Thursday, May 7, 2020 7:28 AM EDT
The dramatic changes caused by Covid-19 have created a number of opportunities.
The Non-Penny Pot Stock Index Was Up 0.8% Wednesday: Here Are The Biggest Winners & Losers
Article By:
Lorimer Wilson
Read
Thursday, May 7, 2020 2:19 AM EDT
On Wednesday the Non-Penny Pot Stock Index (NPSI) of 35 stocks advanced 0.8% with 16 constituents (45.5%) advancing, 16 constituents (45.5%) declining and 3 (9%) constituents experiencing no change in price. This article presents the details.
Biotech M&A Deal Looks Too Rich For Its Blood
Article By:
Lipper Alpha Insight
Read
Wednesday, May 6, 2020 10:46 AM EDT
Alexion Pharmaceuticals (ALXN) is either buying Portola Pharmaceuticals (PTLA) on the cheap at $1.4 billion, or paying a whopping premium – it all depends on your starting date.
Markets Level Off As Trade Talks Commence
Article By:
Adam Vettese
Read
Wednesday, May 6, 2020 5:26 AM EDT
A fairly flat open for European markets this morning as momentum subsides in the rally, thanks to lockdown easing and oil resurgence. Increasingly tense US-China relations were offset by a fairly neutral valuation of the Yuan.
In this article: BP, CVS, DIS, GM, RCL, REGN, GILD, NFLX, WYNN, DIA, SPY, TMUS, BITCOMP, PYPL, SQ, LYFT, UBER
Pot Stock Index Up 0.6% Tuesday: Here Are The Biggest Winners & Losers
Article By:
Lorimer Wilson
Read
Tuesday, May 5, 2020 7:42 PM EDT
On Tuesday the Non-Penny Pot Stock Index of 35 stocks advanced 0.6% of which 19 advanced, 13 declined, 3 had no change in price and 6 of the 9 industry categories advanced. Here are the days major winners and losers .